Epigenetic therapy in gastrointestinal cancer: the right combination

E Abdelfatah, Z Kerner, N Nanda… - Therapeutic advances …, 2016 - journals.sagepub.com
Epigenetics is a relatively recent field of molecular biology that has arisen over the past 25
years. Cancer is now understood to be a disease of widespread epigenetic dysregulation …

The promise of epigenetic therapy: reprogramming the cancer epigenome

AD Kelly, JPJ Issa - Current opinion in genetics & development, 2017 - Elsevier
Epigenetics refers to heritable molecular determinants of phenotype independent of DNA
sequence. Epigenetic features include DNA methylation, histone modifications, non-coding …

Epigenetic events in gastrointestinal cancer

FM Selaru, S David, SJ Meltzer… - Official journal of the …, 2009 - journals.lww.com
Epigenetics refers to heritable changes in gene expression that are, unlike mutations, not
attributable to alterations in DNA sequence. Two predominant epigenetic mechanisms are …

Methylation modification in gastric cancer and approaches to targeted epigenetic therapy

XQ Zeng, J Wang, SY Chen - … journal of oncology, 2017 - spandidos-publications.com
Gastric cancer (GC) is one of the most common cancers and the second leading cause of
cancer-related mortality. Increasing discoveries have highlighted aberrant epigetic …

Epigenetic therapy for solid tumors: from bench science to clinical trials

YY Juo, XJ Gong, A Mishra, X Cui, SB Baylin… - …, 2015 - Taylor & Francis
The cancer epigenome is characterized by global DNA methylation and chromatin changes,
such as the hypermethylation of specific CpG island promoters. Epigenetic agents like DNA …

DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies

DJ Weisenberger, G Liang, HJ Lenz - Oncogene, 2018 - nature.com
Colorectal cancer (CRC) is a worldwide health concern with respect to both incidence and
mortality, and as a result, CRC tumorigenesis, progression and metastasis have been …

[HTML][HTML] Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges

AG Vaiopoulos, KC Athanasoula… - Biochimica et Biophysica …, 2014 - Elsevier
Colorectal cancer, a leading cause of mortality worldwide, is a multistep disorder that results
from the alteration of genetic and epigenetic mechanisms under contextual influence …

Targeting cancer epigenetics: Linking basic biology to clinical medicine

K Shinjo, Y Kondo - Advanced drug delivery reviews, 2015 - Elsevier
Recent studies provide compelling evidence that epigenetic dysregulation is involved in
almost every step of tumor development and progression. Differences in tumor behavior …

Repositioning FDA-approved drugs in combination with epigenetic drugs to reprogram colon cancer epigenome

NJM Raynal, EM Da Costa, JT Lee, V Gharibyan… - Molecular cancer …, 2017 - AACR
Epigenetic drugs, such as DNA methylation inhibitors (DNMTi) or histone deacetylase
inhibitors (HDACi), are approved in monotherapy for cancer treatment. These drugs …

[HTML][HTML] DNA and histone methylation in gastric carcinogenesis

DQ Calcagno, CO Gigek, ES Chen… - World journal of …, 2013 - ncbi.nlm.nih.gov
Epigenetic alterations contribute significantly to the development and progression of gastric
cancer, one of the leading causes of cancer death worldwide. Epigenetics refers to the …